The Cohort Study of Uveitis Patients Based on Real-world Data
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Uveitis
- Sponsor
- Zhongshan Ophthalmic Center, Sun Yat-sen University
- Enrollment
- 600
- Locations
- 1
- Primary Endpoint
- The socre of anterior chamber inflammation based on the Standardization of Uveitis Nomenclature (SUN) scoring system
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
This study intends to explore the epidemiology, pathogenesis, clinical manifestations, diagnosis and treatment of uveitis. This is a cohort study. The outcome of the study is the activity of inflammation and visual prognosis. The purpose of this study is to determine the optimal diagnosis and treatment scheme for uveitis patients based on real-world data.
Investigators
Eligibility Criteria
Inclusion Criteria
- •The diagnosis is uveitis; The agreement of enrolling this study;
Exclusion Criteria
- •Uveitis during the first month after any intraocular surgery; \<18 years; pregnant and lactating women; other conditions are unsuitable for participation in this study by the investigator such as mental abnormalities.
Outcomes
Primary Outcomes
The socre of anterior chamber inflammation based on the Standardization of Uveitis Nomenclature (SUN) scoring system
Time Frame: 12 months post-treatment
activity of anterior chamber inflammation based on the Standardization of Uveitis Nomenclature (SUN) scoring system
The range of inflammatory chorioretinal and/or inflammatory retinal vascular lesions
Time Frame: 12 months post-treatment
inflammatory chorioretinal and/or inflammatory retinal vascular lesions were evaluated by fundus fluorescein angiography and indocyanine green angiography
Secondary Outcomes
- The number of intraocular pressure(6 months post-treatment)
- The number of Intraocular pressure(36 months post-treatment)
- Central retinal thickness(36 months post-treatment)
- The range of inflammatory chorioretinal and/or inflammatory retinal vascular lesions(36 months post-treatment)
- Best corrected visual acuity(36 months post-treatment)
- The socre of anterior chamber inflammation based on the Standardization of Uveitis Nomenclature (SUN) scoring system(36 months post-treatment)